Neurocrine Biosciences (Brazil) Market Value
| N1BI34 Stock | 36.16 0.49 1.37% |
| Symbol | Neurocrine |
Neurocrine Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Neurocrine Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Neurocrine Biosciences.
| 02/04/2023 |
| 11/25/2024 |
If you would invest 0.00 in Neurocrine Biosciences on February 4, 2023 and sell it all today you would earn a total of 0.00 from holding Neurocrine Biosciences or generate 0.0% return on investment in Neurocrine Biosciences over 660 days. Neurocrine Biosciences is related to or competes with CVS Health, Healthpeak Properties, SVB Financial, Sumitomo Mitsui, Home Depot, Capital One, and Credit Acceptance. More
Neurocrine Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Neurocrine Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Neurocrine Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 19.0 | |||
| Value At Risk | (3.04) | |||
| Potential Upside | 3.5 |
Neurocrine Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neurocrine Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Neurocrine Biosciences' standard deviation. In reality, there are many statistical measures that can use Neurocrine Biosciences historical prices to predict the future Neurocrine Biosciences' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (0.75) |
Neurocrine Biosciences Backtested Returns
Neurocrine Biosciences has Sharpe Ratio of -0.0662, which conveys that the firm had a -0.0662% return per unit of risk over the last 3 months. Neurocrine Biosciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neurocrine Biosciences' Standard Deviation of 2.83, risk adjusted performance of (0.04), and Mean Deviation of 1.35 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.22, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Neurocrine Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Neurocrine Biosciences is expected to be smaller as well. At this point, Neurocrine Biosciences has a negative expected return of -0.19%. Please make sure to verify Neurocrine Biosciences' kurtosis, rate of daily change, and the relationship between the skewness and daily balance of power , to decide if Neurocrine Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.02 |
Very weak reverse predictability
Neurocrine Biosciences has very weak reverse predictability. Overlapping area represents the amount of predictability between Neurocrine Biosciences time series from 4th of February 2023 to 31st of December 2023 and 31st of December 2023 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Neurocrine Biosciences price movement. The serial correlation of -0.02 indicates that only 2.0% of current Neurocrine Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.02 | |
| Spearman Rank Test | 0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 8.24 |
Neurocrine Biosciences lagged returns against current returns
Autocorrelation, which is Neurocrine Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Neurocrine Biosciences' stock expected returns. We can calculate the autocorrelation of Neurocrine Biosciences returns to help us make a trade decision. For example, suppose you find that Neurocrine Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Neurocrine Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Neurocrine Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Neurocrine Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Neurocrine Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Neurocrine Biosciences Lagged Returns
When evaluating Neurocrine Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Neurocrine Biosciences stock have on its future price. Neurocrine Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Neurocrine Biosciences autocorrelation shows the relationship between Neurocrine Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Neurocrine Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Neurocrine Stock
When determining whether Neurocrine Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neurocrine Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurocrine Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurocrine Biosciences Stock:Check out Neurocrine Biosciences Correlation, Neurocrine Biosciences Volatility and Neurocrine Biosciences Alpha and Beta module to complement your research on Neurocrine Biosciences. For information on how to trade Neurocrine Stock refer to our How to Trade Neurocrine Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Neurocrine Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.